Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer

Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer

Bibliographic Details
Main Authors:	Mengjun Zhang, Yunduo Liu, Yuan Liu, Siyu Hou, Hao Li, Ying Ma, Can Wang, Xiuwei Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Genetics
Subjects:	arrestin domain containing 2 biomarker immunity prognosis ovarian cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.978493/full

Similar Items

A Potential Indicator ARRDC2 Has Feasibility to Evaluate Prognosis and Immune Microenvironment in Ovarian Cancer
by: Mengjun Zhang, et al.
Published: (2022-05-01)

Baicalin suppresses colorectal cancer cell proliferation, potentially via ARRDC4: Bioinformatics and experimental analysis
by: Shuai Yan, et al.
Published: (2023-10-01)

ARRDC3 as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer Based on Data Mining
by: Chen Y, et al.
Published: (2021-03-01)

Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer
by: Ji-Won Ryu, et al.
Published: (2023-03-01)

Identification of Subpathway Signatures For Ovarian Cancer Prognosis by Integrated Analyses of High-Throughput miRNA and mRNA Expression
by: Songyu Tian, et al.
Published: (2017-11-01)

The Predominant Role of Arrestin3 in General GPCR Desensitization in Platelets
by: Preeti Kumari Chaudhary, et al.
Published: (2021-10-01)

Interaction of Protease-Activated Receptor 2 with G Proteins and Beta-Arrestin 1 Studied by Bioluminescence Resonance Energy Transfer
by: Mohammed Akli eAyoub, et al.
Published: (2013-12-01)

β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation
by: Bastian Czogalla, et al.
Published: (2020-09-01)

Corrigendum: Biomarking and induction of apoptosis in ovarian cancer using bifunctional polyethyleneimine-caged platinum nanoclusters
by: Mengjun Zhang, et al.
Published: (2022-07-01)

Targeting Endothelin-1 Receptor/β-Arrestin-1 Axis in Ovarian Cancer: From Basic Research to a Therapeutic Approach
by: Piera Tocci, et al.
Published: (2019-09-01)

Hepatocyte Deubiquitinating Enzyme OTUD5 Deficiency is a Key Aggravator for Metabolic Dysfunction-Associated Steatohepatitis by Disturbing Mitochondrial HomeostasisSummary
by: Jingjing Dai, et al.
Published: (2024-01-01)

Ovarian Tumor Domain‐Containing 7B Attenuates Pathological Cardiac Hypertrophy by Inhibiting Ubiquitination and Degradation of Krüppel‐Like Factor 4
by: Bin‐Bin Du, et al.
Published: (2023-12-01)

GRKs as Modulators of Neurotransmitter Receptors
by: Eugenia V. Gurevich, et al.
Published: (2020-12-01)

Solo vs. Chorus: Monomers and Oligomers of Arrestin Proteins
by: Vsevolod V. Gurevich, et al.
Published: (2022-06-01)

Corrigendum: Biased signaling of protease-activated receptors
by: Peishen eZhao, et al.
Published: (2015-01-01)

Three Genes Predict Prognosis in Microenvironment of Ovarian Cancer
by: Ya Guo, et al.
Published: (2020-09-01)

The Clinical Significance of β-arrestin 2 Expression in the Serum of  Non-small Cell Lung Cancer Patients
by: Zhengqing WU, et al.
Published: (2011-06-01)

Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer
by: Zitao Wang, et al.
Published: (2022-06-01)

Spatiotemporal control of genome engineering in cone photoreceptors
by: Nan-Kai Wang, et al.
Published: (2023-06-01)

RGS9‐2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models
by: Paola Bonsi, et al.
Published: (2019-01-01)

Historical Perspective of the G Protein-Coupled Receptor Kinase Family
by: Jeffrey L. Benovic
Published: (2021-03-01)

New Insights into Arrestin Recruitment to GPCRs
by: Martin Spillmann, et al.
Published: (2020-07-01)

Scaffolding of Mitogen-Activated Protein Kinase Signaling by β-Arrestins
by: Kiae Kim, et al.
Published: (2022-01-01)

Molecular Mechanisms of Action of FSH
by: Livio Casarini, et al.
Published: (2019-05-01)

Isoflurane induces Art2‐Rsp5‐dependent endocytosis of Bap2 in yeast
by: Fumi Kozu, et al.
Published: (2021-11-01)

Therapeutic Potential of Targeting ß-Arrestin
by: Richard A. Bond, et al.
Published: (2019-03-01)

Tumor Immune Microenvironment Related Gene-Based Model to Predict Prognosis and Response to Compounds in Ovarian Cancer
by: Jiang Yang, et al.
Published: (2021-12-01)

A lactate metabolism-related signature predicting patient prognosis and immune microenvironment in ovarian cancer
by: Linhua Zhu, et al.
Published: (2024-03-01)

Neoantigens and the tumor microenvironment play important roles in the prognosis of high-grade serous ovarian cancer
by: Hua Yang, et al.
Published: (2022-01-01)

Prognosis of lymphadenectomy in malignant ovarian germ cell tumor
by: Bin Lv, et al.
Published: (2023-04-01)

CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment
by: Ying Zhu, et al.
Published: (2020-04-01)

Enterolactone has stronger effects than enterodiol on ovarian cancer
by: Huidi Liu, et al.
Published: (2017-07-01)

Tumor microenvironment in ovarian cancer peritoneal metastasis
by: Shuangshuang Mei, et al.
Published: (2023-01-01)

A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer
by: Jiani Yang, et al.
Published: (2023-09-01)

Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer
by: Jiani Yang, et al.
Published: (2023-01-01)

Immune Subtypes Characterization Identifies Clinical Prognosis, Tumor Microenvironment Infiltration, and Immune Response in Ovarian Cancer
by: Weihong Lu, et al.
Published: (2022-03-01)

Comprehensive Analysis of the Tumor Microenvironment and Ferroptosis-Related Genes Predict Prognosis with Ovarian Cancer
by: Xiao-xue Li, et al.
Published: (2021-11-01)

Feasibility and ability of laparoscopy to predict respectability in ovarian cancer: A cohort study
by: Mohammed Abdelrahman, et al.
Published: (2023-01-01)

A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer
by: Jiani Yang, et al.
Published: (2023-04-01)

Is ovarian cystectomy feasible for patients with borderline ovarian tumors? A retrospective study and review of the literature
by: Seongmin Kim, et al.
Published: (2022-02-01)